Loading insider data...
EVP, Head of R&D | Chief Medical Officer
4 companies
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | ATRA | EVP, Head of R&D | Sell | 5,074 | $3.63 | $18,403.40 | -1.7% | → |
| 2022-11-16 | ATRA | EVP, Head of R&D | Sell | 4,342 | $4.49 | $19,496.70 | -1.4% | → |
| 2022-08-16 | ATRA | EVP, Head of R&D | Sell | 4,124 | $5.03 | $20,760.22 | -2.5% | → |
| 2022-05-17 | ATRA | EVP, Head of R&D | Sell | 3,873 | $5.32 | $20,596.61 | -2.3% | → |
| 2022-03-01 | ATRA | EVP, Head of R&D | Sell | 2,221 | $9.86 | $21,890.18 | -1.3% | → |
| 2022-02-10 | ATRA | EVP, Head of R&D | Sale+OE | 5,000 | $16.00 | $80,000.00 | -5.2% | → |
| 2022-01-03 | ATRA | EVP, Head of R&D | Sale+OE | 5,000 | $16.01 | $80,050.00 | -5.2% | → |
| 2021-12-01 | ATRA | EVP, Head of R&D | Sale+OE | 5,000 | $17.94 | $89,688.50 | -5.2% | → |
| 2021-11-16 | ATRA | EVP, Head of R&D | Sell | 2,199 | $17.12 | $37,640.06 | -2.4% | → |
| 2021-11-02 | ATRA | EVP, Head of R&D | Sale+OE | 5,000 | $16.41 | $82,050.00 | -5.1% | → |
| 2021-08-17 | ATRA | EVP, Head of R&D | Sell | 2,152 | $12.53 | $26,968.86 | -2.3% | → |
| 2021-05-18 | ATRA | EVP, Head of R&D | Sell | 5,184 | $14.55 | $75,427.20 | -5.2% | → |
| 2019-12-30 | GOSS | Chief Medical Officer | Sale+OE | 41,994 | $15.04 | $631,538.11 | -100% | → |